• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Researchers Report First “Routine Clinical Use” of AI for Breast Biopsies

Researchers Report First “Routine Clinical Use” of AI for Breast Biopsies

by Rachel Muenz | Feb 1, 2023 | News

While AI as a diagnostic tool is still years away from regular clinical use, recent research is an important step.

Labs Partner with Pharma Companies to Develop New CDx Tests

Labs Partner with Pharma Companies to Develop New CDx Tests

by Glenn S. Demby | Jan 31, 2023 | Deals-lir, Laboratory Industry Report

There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.

This content is for Paid Members only.
Login Register
An AI Invasion: Improving Breast Cancer Biopsies

An AI Invasion: Improving Breast Cancer Biopsies

by Miriam Bergeret, MSc | Jan 27, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.

This content is for Paid Members only.
Login Register
New Cancer Diagnostic Tests Stand Out

New Cancer Diagnostic Tests Stand Out

by Rachel Muenz | Jan 24, 2023 | News

Key Dx announcements last week involved companion diagnostics, liquid biopsy assays, and an RUO leukemia test.

Guardant Health Leads Wave of New Cancer Diagnostics Collaborations

Guardant Health Leads Wave of New Cancer Diagnostics Collaborations

by Glenn S. Demby | Jan 4, 2023 | Deals-lir, Laboratory Industry Report

Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com